Since the early 1980s when they and others discovered the T-cell receptor, the crucial immune-system element that recognizes foreign substances in the body, National Jewish Health scientists and world-renowned immunologists Drs. Philippa Marrack and John Kappler have continued to make significant contributions to our understanding of disease, leading to better therapies for cancer, allergies and other infections. Find out how their current work is helping us move closer to cures and treatments for immune-related lung diseases including scleroderma and sarcoidosis, as well as type 1 diabetes, lupus, multiple sclerosis and more. They will also give an update on the impact of COVID-19 on autoimmune diseases and the importance of delivering a safe and effective COVID-19 vaccine. To sign up for future Dialogue with a Doc discussions, please visit njhealth.org/DocSeries

Dr. Marrack
https://www.nationaljewish.org/doctor...

Dr. Kappler
https://www.nationaljewish.org/doctor...

Type 1 Diabetes Research
https://www.nationaljewish.org/about/...

Department of Immunology
https://www.nationaljewish.org/doctor...

Kappler Marrack Research Lab
https://www.nationaljewish.org/resear...

Journal of Experimental Medicine
Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation
https://www.ncbi.nlm.nih.gov/pmc/arti...

COVID-19 Information
https://www.nationaljewish.org/patien...